Bio-Key International Overview
Latest ROE for Bio-Key International: -54.07% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-54.07%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Bio-Key International's return on equity stands at -54.07%. That is below the Technology sector average of 47.42%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Bio-Key International sits lower the Technology benchmark (47.42%) with a ROE of -54.07%. That is roughly 214.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of -54.07% for Bio-Key International means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Bio-Key International's ROE evolved across reporting periods, while the comparison chart places BKYI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Technology, ROE is commonly used to spot outliers. Bio-Key International's reading of -54.07% (sector avg 47.42%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
